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P2X receptors for ATP comprise a distinct family of ligand-
gated cation channels with two transmembrane segments,
and a large extracellular ligand binding loop with intracel-
lular amino and carboxy termini (for reviews of properties
see Egan et al. 2004; Burnstock 2006; Khakh and North
2006; Roberts et al. 2006; Surprenant and North 2009).
There are seven mammalian P2X receptor subunits (P2X1–7)
which can form homo- and hetero-trimeric receptors with a
range of properties (North 2002). P2X1 receptors play
important roles in neurogenic smooth muscle contraction
(Mulryan et al. 2000; Vial and Evans 2000, 2002), platelet
activation (Hechler et al. 2003; Mahaut-Smith et al. 2004),
as well as neuronal (Calvert and Evans 2004; Watano et al.
2004) and glial cell responses (Lalo et al. 2008). A
characteristic feature of P2X1 receptors is that they show
rapid receptor desensitisation (time constant 250 ms), and
 5 min is required for recovery following agonist washout
(Valera et al. 1994; Lewis and Evans 2000). The mecha-
nisms underlying recovery from desensitisation remain
unclear. The run-down of P2X1 receptor currents in whole
cell recordings, but not in permeabilised patches, suggests
that intracellular factors are involved (Lewis and Evans
2000). In addition, P2X1 receptors have been reported to
internalise following activation (Dutton et al. 2000; Li et al.
2000; Ennion and Evans 2001) that may also contribute to
the desensitisation process. P2X1 receptors can also be
potentiated by activation of Gaq G protein coupled receptors
(GPCRs) and phorbol esters, e.g. phorbol-12-myristate-13-
acetate (PMA) (Vial et al. 2004; Ase et al. 2005; Wen and
Evans 2009), however the underlying mechanism of this
cross-sensitisation and the extent to which the P2X1 receptor
can be regulated by other classes of GPCRs is unknown.
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Abstract
P2X1 receptors for ATP contribute to signalling in a variety of
cell types and following stimulation undergo rapid desensiti-
sation (within 1 s), and require 5 min to recover. In HEK293
cells P2X1 receptors C-terminally tagged with enhanced
green ﬂuorescent protein (P2X1-eGFP) were predominantly
expressed at the cell surface. Following > 90% photo-
bleaching of P2X1-eGFP within a 6 lm
2 circle at the cell
surface ﬂuorescence recovery after photo-bleaching (FRAP)
was ﬁt with a time constant of 60 s and recovered to 75%
of pre-bleach levels. Following activation of the P2X1 receptor
with a,b-methylene ATP the associated calcium inﬂux doubled
the FRAP recovery rate. The protein synthesis inhibitor
cycloheximide had only a small effect on repeated FRAP and
indicated a limited contribution of new P2X1 receptors to the
FRAP. Inhibition of trafﬁcking with brefeldin A reduced
recovery and this effect could be reversed following receptor
activation. In contrast, the dynamin inhibitor dynasore had no
effect on FRAP under unstimulated conditions but reduced the
level of recovery following agonist stimulation. In functional
studies both brefeldin A and dynasore increased the recovery
time from desensitisation. Taken together these studies
demonstrate for the ﬁrst time an important role of receptor
recycling on P2X1 receptor responsiveness.
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regulation of responsiveness. A conserved YXXXK mem-
brane targeting sequence in the intracellular C-terminal
domain is important for delivery of P2X receptors to the cell
surface and disruption of this motif reduced ATP-evoked
currents by > 95% (Chaumont et al. 2004). P2X4 receptors
show constitutive internalisation through a dynamin depen-
dent pathway (Bobanovic et al. 2002) and sequestration to
lysosomes (Qureshi et al. 2007). P2X3 receptors also show
constitutive receptor internalisation however agonist stimu-
lation leads to transient up-regulation of surface receptor
expression and subsequent acceleration of internalization
(Vacca et al. 2009). To date, however it is unclear what role
trafﬁcking or membrane diffusion plays in the characteristic
rapid desensitisation and slow recovery process exhibited by
P2X1 receptors. Fluorescent recovery after photo-bleaching
(FRAP) of green ﬂuorescent protein-tagged receptors and ion
channels has been used to track channel movement (e.g.
O’Connell et al. 2006) and gives a real time measure of
mobility. For example, FRAP has been used to monitor
P2X2-enhanced green ﬂuorescent protein (eGFP) dynamics
(Chaumont et al. 2008) and receptor activation leads to
receptor redistribution in hippocampal neurons (Khakh et al.
2001).
The recovery of ﬂuorescence following photo-bleaching
can result from the trafﬁcking of new receptors to the cell
surface, receptor recycling, and/or lateral diffusion of
receptors from adjacent stretches of the plasma membrane.
For example the trafﬁcking of newly synthesised receptors
regulates P2X3 receptor surface expression (Vacca et al.
2009) and recycling plays a role in epithelial sodium channel
expression (Butterworth et al. 2005). In the present study we
have used FRAP to determine the mobility and trafﬁcking of
P2X1 receptors with eGFP fused to the C-terminus (P2X1-
eGFP). We show that P2X1 receptors exhibit both constit-
utive and agonist induced recycling that contribute to
recovery from desensitisation. Overall the results show that
recycling plays an important role in the regulation of P2X1
receptor responsiveness.
Methods
Generation of enhanced green ﬂuorescent protein-tagged P2X
receptors
Oligonucleotides were designed to add the restriction sites HindIII
and BamH1 to the N- and C-terminus respectively of the human
P2X1 receptor (Vial and Evans 2005). Similarly HindIII and EcoR1
were added to the N- and C-terminus respectively of the human
P2X2 receptor. Using these sites P2X receptors were sub-cloned into
the multiple cloning site of the peGFP-N1 vector (Clontech,
Basingstoke, UK.), making sure that it was in frame with the eGFP
coding sequences with no intervening in-frame stop codons (stop
codon point mutated to tryptophan). The sequence integrity of all
constructs was veriﬁed by DNA sequencing using Leicester
University PNACL services.
Cell culture and transfection of HEK293 cells
Native HEK293 were maintained in minimal essential medium with
Earle’s Salts (with GlutaMAX  I, Invitrogen, Carlsbad, CA, USA)
supplemented with 10% foetal bovine serum and 1% non-essential
amino acids (Invitrogen) at 37 C in a humidiﬁed atmosphere of 5%
CO2 and 95% air. A monolayer of native cells at 80–90% conﬂuence
in a 24-well culture dish was transiently transfected using 0.5 lg
DNA (human P2X1-eGFP, human P2X2-eGFP or eGFP) and 1 lL
lipofectamine 2000 (Invitrogen) in 500 lL of serum-free Opti-
MEM1. After 24-h incubation, cells were plated onto 25 mm No 0
or 13 mm No 1 coverslips for FRAP and electrophysiological
experiments and left to grow in Dulbecco’s modiﬁed Eagle’s
medium cell culture medium. Cells were subjected to experiments
24–48 h after transfection.
FRAP measurements
Confocal ﬂuorescence measurements were made on an Olympus
inverted microscope with a confocal laser scanning module
(Olympus FluoView1000, Southend on Sea, Essex, UK). Cells
were observed with a 60· oil immersion objective lens (UPLSAPO
60XO, NA 1.35, Southend on Sea, Essex, UK). eGFP ﬂuorescence
was monitored using 488 nm excitation and 500–600 nm emission.
Images were collected at a rate of 0.5 Hz. Each FRAP experiment
started with collection of 30 baseline control images of the cell
followed by a 1-s duration photo-bleach of the region of interest
using high intensity 488 nm illumination sufﬁcient to photobleach
> 90% of the eGFP ﬂuorescence. Typically, 100 images were then
recorded at normal laser intensity after bleaching. A 40 mW multi-
line argon laser was used for both imaging and photobleach, at
outputs of 0.8% and 20% respectively of the 488 nm line. Average
ﬂuorescence intensities of bleached, non-bleached, and background
regions were recorded for each time point. Fluorescence signals
were background-subtracted, corrected for fading of ﬂuorescence
during experiment and expressed as F/Fi ratios to normalise
ﬂuorescence levels (F) against starting ﬂuorescence (Fi). Fluores-
cence intensities of the region of interest were obtained using
FluoView software and plotted. In experiments with cycloheximide
(10 lg/mL for 2 h), brefeldin A (10 lg/mL for 2 h) or dynasore
(80 lM for 1 h) cells were pre-treated in drug-containing solution
before the experiment. Rapid drug application from a U-tube
perfusion system caused cellular movement incompatible with
FRAP measurements, thus for studies of P2X1 receptor activation
a,b-methylene ATP (a,b-meATP, 1 lM) was applied directly to the
cells just before the FRAP imaging.
Electrophysiological recordings and solutions
Permeabilized patch voltage-clamp recordings were made from
HEK293 cells using a Axopatch 200B ampliﬁer (Axon Instru-
ments, Union City, CA, USA). Membrane currents were recorded
at a holding potential of )70 mV (corrected for tip potential).
Data were low pass-ﬁltered at 1 kHz, digitized at a sampling
interval of 200 ls and acquired using a Digidata 1200 analogue-
to-digital converter with pClamp 9.2 acquisition software (Molec-
ular Devices, Palo Alto, CA, USA). Microelectrodes were ﬁlled
with internal solution composed of (in mM) K gluconate, 140;
EGTA, 10; HEPES, 10; NaCl, 5 (pH 7.3, adjusted with KOH) and
had resistances in the range of 2–6 MW. For perforated patch
pipette recordings amphotericin B was added to the internal
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continuously perfused with extracellular solution containing (in
mM) NaCl, 150; KCl, 2.5; CaCl2, 2.5; MgCl2, 1; HEPES, 10;
glucose, 10 (pH 7.3, adjusted with NaOH). a,b-meATP was
applied with a U-tube perfusion system. Repeated applications of
agonist were separated by 5 min in order to allow recovery from
receptor desensitization. In experiments with brefeldin A (10 lg/
mL for 2 h) or dynasore (80 lM for 1 h) cells were pre-treated in
drug-containing solution before the experiment. During the
permeabilized patch recording PMA (100 nM), forskolin
(10 lM) or somatostatin (500 nM) were added to extracellular
solution. Control for treated cells was done every day therefore
the comparisons between non-treated and treated cells were made
between the cells from the same batch. All chemicals were
purchased from Sigma (Poole, Dorset, U.K.).
Data analysis
Data were analyzed with CLAMPFIT (Molecular Devices) or
ORIGIN 6.0 (Microcal Software, Northampton, MA, USA). The
kinetics of recovery were analysed by ﬁtting the curve of
ﬂuorescence intensity with model curves with monoexponential
rise and decay phases (Fig. 1b). The time constant of recovery (s)
was determined as the time constant of fast component and
optimized by the gradient method to minimize the mean square
error (Pankratov and Krishtal 2003). Data in the text and graphs are
shown as mean ± SEM from n determinations as indicated and
analyzed using the unpaired Student’s t-test and p < 0.05 was
considered signiﬁcant.
Results
Characterisation of P2X1 FRAP
P2X1-eGFP ﬂuorescence was observed predominantly at the
plasma membrane and associated with intracellular structures
of cells transiently transfected with P2X1-eGFP DNA
(Fig. 1a). The addition of the eGFP tag to the C-terminus
of the P2X1 receptor had no effect on agonist sensitivity
(a,b-meATP pEC50 5.48 ± 0.10 and 5.53 ± 0.07, Hill slope,
2.1 ± 0.4 and 1.8 ± 0.2, current density 234 ± 38 and
245 ± 44 pA/pF, for P2X1 wild type and P2X1-eGFP
respectively), or desensitisation (time constant for decay
242 ± 25 and 238 ± 18 ms respectively for P2X1 wild type
and P2X1-eGFP) and was therefore used in FRAP studies to
investigate receptor mobility. For photo-bleaching, a 6 lm
2
circle was selected at the cell surface and illuminated with
high intensity 488 nm light for 1 s (see methods for further
details) sufﬁcient to cause an  90% decrease in ﬂuorescence
within the selected region. There was  75% recovery of
ﬂuorescence to the bleached area within 5–6 min (Fig. 1).
The recovery was ﬁt with a fast single exponent (f) with a
time constant (s) of 63.1 ± 1.5 s (n = 67) and a sustained
bleached (s) component (Fig. 1b). There was a linear
correlation between the recovery rate and the area of
photo-bleaching within the range of 3–9 lm
2 (data not
shown). The recovery could result from a combination of
lateral diffusion of P2X1-eGFP tagged receptors from the
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Fig. 1 Characterization of P2X1 receptor mobility by FRAP. (a)
HEK293cellsweretransfectedwithP2X1-eGFPDNA.Righthandpanel
shows the whole cell and the square is shown at higher power in a time
series of ﬂuorescent images. Images were obtained with the laser
scanning confocal microscope before (ﬁrst minute) and after photo-
bleaching of the region indicated by the circle. (b) Example of P2X1
receptor FRAP ﬁt by two components. The black jagged line represents
the experimental curve. The lines labelled f and s represent the fast and
slow/sustainedcomponentsoftherecovery,thegraylinerepresentsthe
sum of the components. Photobleach is indicated by the star. (c) Dis-
tribution of recovery time constants and immobile fractions of individual
cells transfected with P2X1-eGFP DNA is independent of the level of
initial ﬂuorescence (n = 67). (d) Representative FRAP traces and
summary data of recovery time constants and immobile fractions for
cells transfected with P2X1-eGFP, P2X2-eGFP and eGFP DNA
(n = 67, 18 and 8 respectively) indicate that FRAP parameters are
subunit speciﬁc. Star indicates photo-bleach. *** p < 0.001.
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or recycling receptors. The sustained bleached fraction
(0.26 ± 0.01, n = 67) corresponds to receptors that were
bleached and remain within the area of interest (Axelrod
et al. 1976) and will subsequently be referred to as the
immobile fraction (Fig. 1c). The recovery time and immobile
fraction were both independent of the level of expression of
eGFP-tagged receptors (Fig. 1c).
For comparison we also determined FRAP for cytosolic
eGFP and surface P2X2-eGFP. When eGFP alone was
expressed in HEK293 cells, recovery from photo-bleaching
was very fast (time-constant 4.01 ± 0.68 s, n = 6) and
complete (Fig. 1d). C-terminally eGFP tagged P2X2 recep-
tors showed FRAP with a similar single exponential recovery
and sustained bleach however recovery was twice as fast as
the P2X1 receptor (31.2 ± 2.1 s, n = 20), and the fraction of
immobile P2X2-eGFP receptors was half that for
P2X1-eGFP (0.14 ± 0.019 and 0.26 ± 0.01 respectively,
p = 0.001). These results demonstrate that P2X receptors
show subunit dependent mobility in the membrane. However
in the present study we have focused our attention on the
mechanisms involved in the regulation of P2X1 receptor
FRAP.
Effects of P2X1 receptor activation on mobility
P2X1 receptors show profound desensitisation on agonist
stimulation. To determine whether activation of the P2X1
receptor inﬂuences mobility we treated HEK293 cells
expressing the P2X1-eGFP receptor with 1 lM a,b-meATP.
Following P2X1 receptor activation the rate of FRAP was
doubled (32.5 ± 2.1 s, n = 17), while the immobile fraction
of receptors was unaffected (Fig. 2). The P2X1 receptor
antagonist phosphate-6-azophenyl-2¢,4¢-disulfonate (PPADS)
(10 lM), applied in the absence of a,b-meATP, had no effect
on the rate of recovery or the immobile fraction (61.4 ± 2.9 s
and 0.23 ± 0.04 s respectively, n = 6) demonstrating that
there was no basal effect of endogenous release of ATP from
the cultured cells. P2X1 receptors show high calcium
permeability and  12% of the current ﬂowing under normal
physiological conditions is carried by calcium (Egan and
Khakh 2004). To test whether receptor activation and/or
calcium inﬂux mediated the speeding in FRAP, we replaced
the calcium in the extracellular solution with barium.
In the absence of agonist barium substitution had no effect
on the speed of recovery but caused a small increase in the
immobile fraction (70.4 ± 6.2 s and 0.32 ± 0.03 s respec-
tively, n = 5, Fig. 2). Replacement of calcium with barium
prevented the acceleration of FRAP by a,b-meATP suggest-
ing that an increase in intracellular calcium plays a key role
in regulating the speed of movement of the receptors (Fig. 2).
Interestingly, a,b-meATP applied with barium also resulted
in a small  15% reduction of the immobile fraction (Fig. 2),
however the underlying reasons for this effect remains to be
determined.
To explore further whether calcium inﬂux alone, or the
combined activation of the P2X receptor, coupled with the
rise in intracellular calcium, was responsible for the accel-
erated FRAP, we raised intracellular calcium independently
*** **
Time (s)
R
e
c
o
v
e
r
y
 
(
s
)
*
**
I
m
m
o
b
i
l
e
 
f
r
a
c
t
i
o
n
0
τ
20
40
60
0.0
0.1
0.2
0.3
***
I
m
m
o
b
i
l
e
 
f
r
a
c
t
i
o
n
0.0
0.1
0.2
0.3
0
20
40
60
R
e
c
o
v
e
r
y
 
(
s
)
*** ** ***
F
/
F
i
,
n
o
r
m
a
l
i
z
e
d
 
f
l
u
o
r
e
s
c
e
n
c
e
Control
α,β-meATP
 α,β-meATP Ba2+
0 50 100 150 200 250
0.2
0.4
0.6
0.8
1.0
(c)
(b)
(a)
Control
PPADS
α,β-meATP
α,β-meATP
α,β-meATP BAPTA
α,β-meATP
α,β-meATP BAPTA
Ba 2+  α,β-meATP
Ba 2+
Control
PPADS
α,β-meATP
Ba 2+  α,β-meATP
Ba 2+
Fig. 2 Speeding of FRAP following P2X1-eGFP receptor activation is
dependent on localized Ca
2+ microdomains. (a) Representative FRAP
traces in control conditions and in the presence of 1 lM a,b-meATP
with calcium or barium in the extracellular solution. (b) FRAP time
constants and immobile fractions in control conditions were not
affected in the presence of PPADS, but activation of P2X1 receptors
by a,b-meATP increased the rate of recovery about twofold (n = 17,
p < 0.0001). This effect of a,b-meATP was abolished when the cal-
cium in the extracellular solution was replaced with barium (n = 10,
p < 0.0001). (c) Summary of the effects of BAPTA (50 lM BAPTA-AM
for 1 h), a,b-meATP, and thapsigargin on FRAP rate and immobile
fraction. These indicate that direct local calcium inﬂux plays a role in
the speeding of FRAP following P2X receptor activation. Star indicates
photo-bleach. ** p < 0.01, *** p < 0.001.
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1180 | U. Lalo et al.with thapsigargin (Ribeiro et al. 2000). A speeding in the
recovery from photo-bleaching, with no effect on the
immobile fraction was also seen following treatment with
thapsigargin (10 min with 1 lM) (time constant for FRAP
45 ± 3.2 s, n = 9) indicating that an increase in calcium
alone, and not co-incident activation of the channel was
sufﬁcient to speed FRAP (Fig. 2c). 1,2-Bis(2-aminophe-
noxy) ethane-N,N,N¢,N¢-tetraacetic acid tetrakis(acetoxy-
methyl ester) (BAPTA-AM) treatment (50 lM, 1 h at
37 C) was used to buffer rises in intracellular calcium and
abolished the increase in recovery from photo-bleaching in
response to thapsigargin but only had a small reduction on
a,b-meATP induced speeding (Fig. 2c). BAPTAwill be more
effective as a buffer of the slow thapsigargin evoked calcium
increases through store release compared to the rapid P2X1
receptor evoked inﬂux. The rapid, and localised microdo-
main of calcium following P2X1 receptor activation, even in
the presence of BAPTA, was sufﬁcient to speed the recovery
from photo-bleaching and suggests that the appreciable
calcium permeability of the P2X1 receptor contributes
locally at the membrane to receptor mobility.
Do newly synthesised P2X receptors contribute to FRAP?
The recovery of ﬂuorescence following photo-bleaching
could result from the migration of receptors already present
at the membrane or trafﬁcking of new receptors to the cell
surface. Cells were given three rounds of photo-bleach to
characterise further recovery from photo-bleaching. The
immobile fraction was initially 0.26 ± 0.04 and increased
on a second photo-bleach to 0.33 ± 0.09 (p < 0.005) and was
then stable on a third bleach at 0.30 ± 0.01 (n = 16). This
stabilisation of the immobile fraction could result from a
fraction of the P2X1 receptors being retained within cell
surface microdomains as shown for Kv2.1 potassium chan-
nels (O’Connell et al. 2006) and thus unable to move out of
the photo-bleach area. Cells were incubated with cyclohex-
imide (10 lg/mL for 2 h), an inhibitor of protein synthesis,
to determine the contribution of trafﬁcking of new P2X1-
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Fig. 3 Turnover of P2X1-eGFP receptors is brefeldin A (BFA) sensi-
tive. (a) Averaged FRAP traces for triple serial photo-bleaching
(bleach indicated by star) of the same area for non-treated (control)
cells, cells treated with cylcloheximide (10 lg/mL for 2 h) or BFA
(10 lg/mL for 2 h). (b) Averaged FRAP traces for triple serial photo-
bleaching of the same area for P2X1-eGFP receptors. When P2X1
receptors were activated with 1 lM a,b-meATP BFA had no effect on
serial photobleaching, however when barium replaced calcium in
the external solution BFA again reduced FRAP. (c) Summary of
the effects of cycloheximide, BFA, a,b-meATP and barium on the
time-course of recovery to the third photobleach. Star indicates photo-
bleach. (d) Summary of the effects of cycloheximide, BFA, a,b-meATP
and barium on the immobile fraction at the end of three rounds of
photobleaching. Star indicates photo-bleach. * p < 0.05, *** p < 0.001.
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effect on the rate of FRAP. Initially there was no effect on the
immobile fraction to the ﬁrst photo-bleach, however follow-
ing three rounds of photo-bleaching there was a  12%
increase in the immobile fraction (Fig. 3a). This suggests that
trafﬁcking of new P2X1 receptors to the cell surface plays
only a small role in receptor turnover in the short term (and
conﬁrms a recent study looking at surface expression of
P2X1 receptors (Vacca et al. 2009).
Does receptor recycling contribute to P2X1 receptors
FRAP?
The limited contribution of newly synthesised P2X1
receptors to FRAP suggests that recovery results predom-
inantly from lateral diffusion of receptors already at the cell
surface and/or the insertion of recycling receptors. To
determine the relative contribution of insertion of recycling
P2X1 receptors we have used the cell-permeant inhibitors
of vesicle trafﬁcking brefeldin A (BFA) (Hunziker et al.
1991; Chardin and McCormick 1999) and the dynamin
inhibitor dynasore (Macia et al. 2006; Thompson and
McNiven 2006).
Brefeldin A treatment (10 lg/mL for 2 h, 37 C) speeded
the recovery rate (33 ± 5.3 s, n = 10) and resulted in a
progressive increase in the immobile fraction following
repeated photo-bleaching (Fig. 3a). At the end of the third
recovery period the immobile fraction had increased from
0.337 ± 0.007 to 0.656 ± 0.003 (n = 10 and p < 0.001)
(Fig. 3). In contrast BFA had no effect on the rate of
recovery or the P2X2 receptor FRAP immobile fraction at
the end of the third photo-bleach (0.27 ± 0.01, n = 6 and
0.24 ± 0.007, n = 5 for control and BFA treated respec-
tively, p = 0.025). This demonstrates that the effects of
BFA on the P2X1 receptor are not the result of non-
speciﬁc effects such as general cellular disruption. The
BFA effect on the P2X1 receptor immobile fraction
suggests that constitutive vesicular trafﬁcking (recycling)
of the receptor makes a signiﬁcant contribution to the
expression of P2X1 receptors at the cell surface. Interest-
ingly, following P2X1 receptor activation with a,b-meATP,
BFA had no effect on the immobile fraction in response to
repeated photo-bleaching (Fig. 3). This rescue of recovery
was abolished when barium replaced calcium in the
extracellular solution (Fig. 3). These results suggest that
in addition to the BFA sensitive constitutive component
there is a calcium-sensitive (BFA-insensitive) pathway
triggered by P2X1 receptor activation that contributes to
receptor trafﬁcking.
Agonist-stimulated receptor recycling can occur through
a dynamin dependent pathway. Dynasore is a cell perme-
able inhibitor of dynamin 1 and dynamin 2 GTPase
activity and has been used to block the formation of
clathrin coated vesicles (for mini review see Thompson and
McNiven 2006). Dynasore (80 lM, 1 h, 37 C) had no
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Fig. 4 Agonist and dynamin dependent P2X1 receptor internalization/
recycling. (a) Averaged FRAP traces for triple serial photo-bleaching
(bleach indicated by star) of the same area for non-treated (control)
cells and cells treated with dynasore (80 lM for 1 h). (b) Averaged
FRAP traces for triple serial photo-bleaching of the same ROI when
P2X1-eGFP receptors were activated by 1 lM a,b-meATP in control
or dynasore treated cells. (c) Summary of the effects of dynasore on
the immobile fraction at the end of the third photo-bleach. Star indi-
cates photo-bleach. ***p < 0.001.
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with no agonist present (Fig. 4). However following P2X1
receptor activation with a,b-meATP there was an increase
in the immobile fraction in successive rounds of photo-
bleaching with a  20% increase at the end of the third
photo-bleach (Fig. 4). These results indicate that P2X1
receptor activation leads to dynamin dependent receptor
internalisation. When dynasore blocks this process there is
reduced FRAP because of a combination of reduced
removal of photo-bleached receptor from the cell surface
and reduced receptor recycling.
Does blocking receptor trafﬁcking regulate P2X1 receptor
currents?
The FRAP studies indicate that the P2X1 receptor shows
both constitutive and agonist induced trafﬁcking however
they do not determine the contribution of trafﬁcking to
responsiveness of the receptor. To address this we have used
patch clamp recording of P2X1 receptor currents. BFA and
dynasore treatment had no effect on the initial response of the
P2X1 receptor to a,b-meATP (Fig. 5) (mean current ampli-
tudes of 257 ± 29, 206 ± 24 and 251 ± 53 pA/pF for control
brefeldin and dynasore treatment respectively, n = 5–3). In
the permeabilised patch conﬁguration a,b-meATP evoked
rapidly desensitising inward P2X1 receptor currents. These
were reproducible when a 5-min interval was given between
applications for recovery from desensitisation as reported
previously (Lewis and Evans 2000). However BFA and
dynasore produced a  50% decrease in the P2X1 receptor
response to the second application of a,b-meATP applied
5 min later. Further studies varying the interval between a,b-
meATP applications showed that both BFA and dynasore
slowed the time-course of receptor recovery from desensi-
tisation (time to 50% recovery 55 s, 300 s and 270 s for
control, BFA and dynasore respectively). These results
suggest that P2X1 receptor trafﬁcking plays an important
role in regulation of repeated P2X1 receptor mediated
responses.
GPCR/second messenger mediated regulation of P2X1
receptors
P2X1 receptor responses can be potentiated by stimulation
of Gaq coupled mGlur1a and P2Y receptors, this effect
can be mimicked by application of the phorbol ester PMA
(Vial et al. 2004; Ase et al. 2005) and involves amino
acids in the intracellular amino terminus (Wen and Evans
2009). However whether this has an effect on receptor
mobility/trafﬁcking or whether Gaio rG as -protein
coupled receptors and signalling pathways can regulate
P2X1 receptors is unknown. We therefore determined the
effects of PMA, forskolin to stimulate protein kinase A
and mimic Gas receptor activation, or stimulation of the
endogenous HEK cell Gai coupled somatostatin receptor
on P2X1 receptor mediated currents and FRAP. PMA
(100 nM) potentiated P2X1 receptor currents by
104.7 ± 17.8% (Fig. 6). Forskolin (10 lM) or somatostatin
(500 nM) had no signiﬁcant effect on P2X1 receptor
currents or on receptor FRAP (Fig. 6). These results
indicate that P2X1 receptors can be regulated by Gaq
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ingly PMA treatment increased the FRAP recovery rate
with no effect on the immobile fraction (the inactive
phorbol ester 4-a-PMA, also 100 nM, had no effect on
recovery rate or immobile fraction) (Fig. 6) suggesting that
an effect on receptor trafﬁcking contributes to the P2X1
receptor potentiation.
Discussion
Fluorescence recovery after photo-bleaching provides a
powerful technique to look at receptor movement in real
time. This approach, along with parallel electrophysiological
studies on P2X1 receptor currents, has allowed us to
investigate the contribution of mobility and trafﬁcking to
P2X1 receptor function. These studies show that the P2X1
receptor is not static on the cell surface but undergoes
considerable mobility and turnover. Following photo-bleach-
ing, recovery of ﬂuorescence can result from the lateral
diffusion of receptors adjacent to the bleach site, as well as
trafﬁcking of receptors to the cell surface. If the ﬂuorescence
does not fully recover this indicates that some of the bleached
receptors remain as an immobile fraction. P2X1-eGFP
receptor ﬂuorescence recovered with a time constant of
 60 s and the immobile fraction accounted for  25% of
the receptors expressed at the surface. These results indicate
that in the 5-min period there is  75% dynamic movement
of the receptors at the cell surface in the bleached area. The
FRAP proﬁle of the P2X2 receptor (faster recovery and
smaller immobile fraction) shows greater mobility in the
membrane. This is interesting as the P2X2 receptor has a
longer C-terminal tail and as a larger protein one might
expect it to move more slowly in the membrane. Therefore,
these results suggest that there are subtype dependent
differences in mobility of the P2X receptors. We have
previously suggested that the P2X1 receptor may be
regulated by interacting proteins (Vial et al. 2004; Wen and
Evans 2009) and the reduced speed of mobility and increased
immobile fraction may reﬂect this.
In this study, we have characterised the contribution of
new and recycling P2X1 receptors to the mobile fraction.
The modest effects of the protein synthesis inhibitor
cycloheximide on FRAP suggest that insertion of newly
synthesised P2X1 receptors at the cell surface makes only a
small contribution to recovery from photo-bleaching. This
is consistent with a recent report on the cell surface
expression of P2X1 receptors (Vacca et al. 2009). It appears
that the importance of newly synthesized receptor is
subtype dependent as P2X7 receptors (Gu and Wiley
2006) also make a limited contribution to receptor turnover
whereas they make a signiﬁcant contribution to P2X3
receptor expression (Vacca et al. 2009). BFA treatment
leads to the collapse of the Golgi and its redistribution to
the endoplasmic reticulum blocking transit of new proteins
to the cell surface (Chardin and McCormick 1999) and has
similar effects to cycloheximide. BFA in addition blocks
other vesicular transport processes (van Dam et al. 2002;
Butterworth et al. 2005; Kim and Ryan 2009). Two lines of
evidence suggest that it is this latter action of BFA, on
vesicular transport, that accounts for the decreased recovery
from FRAP (increased immobile fraction) for the P2X1
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recovery (this study) or surface expression (Vacca et al.
2009) suggests that new protein synthesis does not play a
major role. Second, if BFA was acting to block the insertion
of new receptors treatment with a,b-meATP would not
rescue the response as new receptors are not available for
trafﬁcking. These results suggest that P2X1 receptors are
constitutively internalised and recycled by a BFA sensitive
pathway. P2X3 and P2X4 receptors also show constitutive
internalisation. This involves ubiquitination of P2X3 recep-
tors (Vacca et al. 2009) and for P2X4 receptors interaction
of a non-canonical motif in the C-terminus that binds the
adaptor protein AP2 (Royle et al. 2005) is involved and a
dileucine-like motif in the N-terminus can target the
receptors to lysosomes (Bobanovic et al. 2002). These
motifs are absent from the P2X1 receptor and the molecular
mechanism underlying BFA sensitivity remains to be
determined. Our results showing the lack of effect of
BFA on P2X2 receptor FRAP support previous studies that
P2X2 receptors are not subject to constitutive internalisation
(Bobanovic et al. 2002) and demonstrate that BFA does not
have a generalised effect on receptor trafﬁcking. Taken
together these results demonstrate signiﬁcant differences in
trafﬁcking between P2X receptor family members.
Activation of the P2X1 receptor with a,b-meATP
increased the rate of recovery from photo-bleaching in a
manner similar to that reported for ATP on P2X2 receptor
mobility (Chaumont et al. 2008). We now show that calcium
inﬂux through the P2X receptor, rather than receptor
activation per se, is mainly responsible for this effect as
the accelerated recovery was mimicked by raising the
intracellular calcium concentration with thapsigargin in the
absence of P2X receptor stimulation. The ability of BAPTA
to block the speeding of recovery by thapsigargin but not by
a,b-meATP further suggests that it is likely to be a localised
effect of a calcium microdomain close to the cell surface.
These results therefore show that P2X receptor activation can
lead to an increase in receptor mobility.
P2X1 receptor activation results in receptor internalisation
and recycling (Dutton et al. 2000; Li et al. 2000; Ennion and
Evans 2001). Dynasore treatment had no effect on P2X1
receptor FRAP in the absence of stimulation. However the
reduction by dynasore of the level of recovery (increased
immobile fraction) following a,b-meATP treatment suggests
that receptor internalisation and recycling were reduced and
bleached P2X1 receptors could not be replaced at the cell
surface. This reduction in recovery in activated P2X1
receptor FRAP (but not at rest) by dynasore suggests that
the agonist stimulated internalization/recycling of the recep-
tor is dynamin/clathrin dependent. The lack of observation of
internalised receptor following agonist stimulation demon-
strates that the receptor is rapidly trafﬁcked back to the cell
surface consistent with previous biochemical studies (Ennion
and Evans 2001).
The different effects of BFA and dynasore on FRAP
suggest that these drugs regulate different aspects of P2X1
receptor trafﬁcking. This is consistent with the opposite
effects of a,b-meATP treatment in response to brefeldin or
dynasore; a,b-meATP treatment reversed the increase in
immobile fraction induced by brefeldin and increased the
immobile fraction following dynasore treatment. For brefel-
din this may result from agonist induced trafﬁcking of the
receptor. For dynasore the increase in immobile fraction
following receptor stimulation suggests that agonist induced
trafﬁcking plays an important role in the cell surface
expression of P2X1 receptors.
Our electrophysiological studies showed that both BFA
and dynasore regulate recovery of P2X1 receptor currents
from desensitisation. Inhibition of trafﬁcking by either BFA
or dynasore reduced the response to a second application of
agonist at 5 min by  50% and increased the time required
for P2X1 receptors to recover from desensitisation. These
results suggest that internalisation and recycling to the cell
surface plays an important role in recovery from desensiti-
sation. One possibility is that the acidic environment that the
extracellular ligand binding domain of the receptor is
exposed to in the endosome could facilitate the dissociation
of agonist from the receptor as has been suggested for other
receptors (Maxﬁeld and McGraw 2004).
The electrophysiological studies also reveal how FRAP
may underestimate the importance of trafﬁcking in recovery
from desensitisation as there was little or no effect on FRAP
with brefeldin or dynasore between the ﬁrst and second
photo-bleach, however P2X1 receptor currents were reduced
by  50% in electrophysiological studies. These discrepan-
cies can be explained by two factors (i) the small area photo-
bleached and (ii) the FRAP technique looks at recovery of
ﬂuorescence and not recovery of receptors from a desensitised
state. In FRAP only the area of interest was photo-bleached.
The pool of adjacent unbleached receptors at the surface
available for lateral diffusion allows initially for signiﬁcant
recovery after the ﬁrst photo-bleach but then on subsequent
bleaching the pool becomes depleted and reduced trafﬁcking
of new receptors becomes apparent as a decrease in the level
of recovery. The electrophysiological studies measure the
functionalactivityofalltheP2Xreceptorsonthecell,whereas
the ﬂuorescence gives a measure of the number of receptors
but not whether they are in an available or desensitised state.
Therefore in FRAP studies the ﬂuorescence recovery may
correspond to movement of desensitised receptors into photo-
bleached area. For example with BFA treatment the recovery
of the immobile fraction with a,b-meATP (that was applied to
the whole cell) may result from increased lateral diffusion of
ﬂuorescent, but desensitised receptors, from an adjacent area
consistent with the increased mobility of the receptors
following receptor activation and calcium inﬂux.
The FRAP and electrophysiological studies suggest that
there are two trafﬁcking pathways for the P2X1 receptor; a
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dynasore-sensitive one. Support for two pharmacologically
distinct pathways comes from a recent study showing that
dynasore dependent internalization of the TRPV5 (transient
receptor potential cation channel, subfamily V, member 5)
calcium channel is blocked by dynasore but not by BFA (van
de Graaf et al. 2008). The electrophysiological studies
clearly show that trafﬁcking can regulate P2X1 receptor
responsiveness. On the other hand, as a positive feedback,
trafﬁcking events can also be regulated by activation of P2X1
receptor. The increase in time constant of recovery of P2X1
FRAP following phorbol ester treatment is consistent with a
decrease in the time required for recovery from desensitisa-
tion (Ase et al. 2005). Overall these studies highlight that
trafﬁcking plays an important role in the control of the
functional expression of P2X1 receptors and their regulation.
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